" class="no-js "lang="en-US"> Thomas Schinecker - Medtech Alert
Sunday, March 03, 2024
Thomas Schinecker

Thomas Schinecker

About Thomas Schinecker

Austrian / German with 18 years experience in the healthcare industry as well as experience in different regions of the world such as Asia (12 years), USA (9 years) and diverse European countries (Sweden, Switzerland, Austria, Germany). The diverse experiences have shaped me as a person and a professional. I enjoy working and living in different cultures.

Related Story

Roche Launches a Digital PCR System, a Powerful New Diagnostics Platform in the Fight Against Cancer and Other Diseases

August 23 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Digital LightCyclerⓇ System, Roche’s first […]

Roche Launches New Diagnostic Test for the Better Understanding of Immune Response to SARS-CoV-2

August 15 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys® IGRA SARS-CoV-2 test […]

Roche Launches Innovative Dual Antigen and Antibody Diagnostic Test Supporting the Fight to Eliminate the Hepatitis C Virus

July 19 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys® HCV Duo […]

Roche Launches New BenchMark ULTRA PLUS System for Cancer Diagnostics Enabling Timely, Targeted Patient Care

June 29 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the BenchMark ULTRA PLUS system, its […]

Roche Launches Human Papillomavirus (HPV) Self-sampling Solution, Expanding Cervical Cancer Screening Options

June 16 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a human papillomavirus (HPV) […]

Roche Develops Unique PCR Tests to Detect the Monkeypox Virus

May 26 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus […]

Roche Enters Partnership With the Global Fund to Support Low- and Middle-income Countries in Strengthening Critical Diagnostics Infrastructure

May 12 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Global Fund […]

Roche Provides Molecular Testing Solutions to Identify and Differentiate SARS-CoV-2 Omicron Variants of Concern

March 17 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol, a subsidiary within the Roche Diagnostics division, […]

Roche Launches the Cobas® Pulse System, an Industry First Professional Blood Glucose Management Solution with Mobile Digital Health Capabilities to Improve Patient Care

January 12 2022

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in […]

Significant Investment Accelerates Freenome's Multiomics Platform for the Early Detection of Cancer

January 12 2022

Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 […]

Roche Launches the AVENIO Edge System to Simplify and Automate Next-generation Sequencing Sample Preparation, Reduce Human Error and Advance Precision Medicine

December 13 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the AVENIO Edge System, […]

Roche to Launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in Countries Accepting the CE Mark to Enable Rapid Differentiation of Viral Respiratory Infections

December 6 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu […]

Roche Has Rapidly Developed Additional Testing Options to Differentiate Mutations in the Omicron SARS-CoV-2 Variant

December 3 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol, a newly acquired subsidiary within the Roche […]

Roche Launches Cobas 5800, a New Molecular Diagnostics System to Expand Access to Testing and Improve Patient Care

November 18 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® 5800 System, a new […]

Roche Launches Comprehensive Genomic Profiling Kit to Expand Access to Personalised Cancer Research

October 25 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has launched the AVENIO Tumor Tissue […]

Roche Announces PathAI Collaboration for Artificial Intelligence-based Digital Pathology Applications for Improved Patient Care

October 15 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with PathAI, […]

Roche Opens Access to Pathology Imaging Tools to Improve Patient Care

September 15 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the introduction of the Roche Digital Pathology Open […]

Roche Receives FDA Approval for First Companion Diagnostic to Identify dMMR Solid Tumour Patients Eligible for Anti-PD-1 Immunotherapy

August 19 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval […]

Roche Launches Elecsys Epstein-barr Virus (Ebv) Immunoassay Panel

March 31 2021

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Elecsys® EBV panel has launched […]